Loading...
Bausch + Lomb Corporation
BLCO•NYSE
Healthcare
Medical - Instruments & Supplies
$14.32
$0.35(2.51%)
Bausch + Lomb Corporation (BLCO) Financial Performance & Income Statement Overview
Review Bausch + Lomb Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
15.15%
↑ 15.15%
Operating Income Growth
24.62%
↑ 24.62%
Net Income Growth
-21.92%
↓ 21.92%
Operating Cash Flow Growth
1464.71%
↑ 1464.71%
Operating Margin
1.80%
↑ 1.80%
Gross Margin
56.97%
↑ 56.97%
Net Profit Margin
-10.16%
↓ 10.16%
ROE
-7.56%
↓ 7.56%
ROIC
0.74%
↑ 0.74%
Bausch + Lomb Corporation (BLCO) Income Statement & Financial Overview
Review Bausch + Lomb Corporation's (BLCO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.28B | $1.20B | $1.22B | $1.10B |
| Cost of Revenue | $501.00M | $536.00M | $557.00M | $498.00M |
| Gross Profit | $779.00M | $660.00M | $659.00M | $601.00M |
| Gross Profit Ratio | $0.61 | $0.55 | $0.54 | $0.55 |
| R&D Expenses | $93.00M | $84.00M | $84.00M | $82.00M |
| SG&A Expenses | $532.00M | $511.00M | $535.00M | $504.00M |
| Operating Expenses | $692.00M | $595.00M | $619.00M | $586.00M |
| Total Costs & Expenses | $1.19B | $1.13B | $1.18B | $1.08B |
| Interest Income | $5.00M | $4.00M | $3.00M | $3.00M |
| Interest Expense | $98.00M | $100.00M | $102.00M | $99.00M |
| Depreciation & Amortization | $106.00M | $110.00M | $110.00M | $110.00M |
| EBITDA | $194.00M | $152.00M | $136.00M | $125.00M |
| EBITDA Ratio | $0.15 | $0.13 | $0.11 | $0.11 |
| Operating Income | $87.00M | $43.00M | $40.00M | $15.00M |
| Operating Income Ratio | $0.07 | $0.04 | $0.03 | $0.01 |
| Other Income/Expenses (Net) | -$97.00M | -$101.00M | -$102.00M | -$96.00M |
| Income Before Tax | -$10.00M | -$58.00M | -$76.00M | -$90.00M |
| Income Before Tax Ratio | -$0.008 | -$0.05 | -$0.06 | -$0.08 |
| Income Tax Expense | -$8.00M | -$66.00M | $72.00M | $73.00M |
| Net Income | -$3.00M | -$124.00M | -$151.00M | -$167.00M |
| Net Income Ratio | -$0.002 | -$0.10 | -$0.12 | -$0.15 |
| EPS | -$0.009 | $0.01 | -$0.43 | -$0.48 |
| Diluted EPS | -$0.009 | $0.01 | -$0.43 | -$0.48 |
| Weighted Avg Shares Outstanding | $351.80M | $351.90M | $351.80M | $351.10M |
| Weighted Avg Shares Outstanding (Diluted) | $351.80M | $353.90M | $351.80M | $351.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan